RIG-I like receptors in antiviral immunity and therapeutic applications

Viruses. 2011 Jun;3(6):906-19. doi: 10.3390/v3060906. Epub 2011 Jun 23.

Abstract

The RNA helicase family of RIG-I-like receptors (RLRs) is a key component of host defense mechanisms responsible for detecting viruses and triggering innate immune signaling cascades to control viral replication and dissemination. As cytoplasm-based sensors, RLRs recognize foreign RNA in the cell and activate a cascade of antiviral responses including the induction of type I interferons, inflammasome activation, and expression of proinflammatory cytokines and chemokines. This review provides a brief overview of RLR function, ligand interactions, and downstream signaling events with an expanded discussion on the therapeutic potential of targeting RLRs for immune stimulation and treatment of virus infection.

Keywords: RIG-I; adjuvant; inflammation.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • DEAD-box RNA Helicases / genetics
  • DEAD-box RNA Helicases / immunology*
  • Enzyme Activators / therapeutic use
  • Humans
  • Immunity, Innate*
  • Virus Diseases / drug therapy
  • Virus Diseases / enzymology*
  • Virus Diseases / immunology*
  • Virus Diseases / virology
  • Virus Physiological Phenomena
  • Viruses / drug effects

Substances

  • Antiviral Agents
  • Enzyme Activators
  • DEAD-box RNA Helicases